PURPOSE: Expression of the type 1 insulin-like growth factor receptor (IGF1R) confers adverse prognosis in clear cell renal cell cancer (CC-RCC). We recently showed that IGF1R expression is inhibited by the von Hippel-Lindau (VHL) tumor suppressor, and the IGF1R is up-regulated in CC-RCC, in which VHL is frequently inactivated. We tested the hypothesis that IGF1R up-regulation mediates resistance to cancer therapeutics, evaluating the effects of IGF1R depletion on sensitivity to cytotoxic dru...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer.
If you are the owner of this record, you can report an update to it here: Report update to this record